神経調節デバイスの市場規模、シェア、動向分析レポート:製品タイプ別(脊髄刺激装置、脳深部刺激装置)、技術別、用途別、生体材料別、最終用途別、地域別、およびセグメント予測、2022年~2030年Neuromodulation Devices Market Size, Share & Trends Analysis Report By Product Type (Spinal Cord Stimulators, Deep Brain Stimulators), By Technology, By Application, By Biomaterial, By End-use, By Region, And Segment Forecasts, 2022 - 2030 神経調節デバイス市場の成長とトレンド グランドビューリサーチ社の最新レポートによると、神経調節デバイスの世界市場規模は2030年までに83億米ドルに達すると予測されています。2022年から2030年にかけては... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー神経調節デバイス市場の成長とトレンドグランドビューリサーチ社の最新レポートによると、神経調節デバイスの世界市場規模は2030年までに83億米ドルに達すると予測されています。2022年から2030年にかけては、CAGR9.5%で拡大すると予測されています。神経調節は、神経疾患の治療において、低侵襲または非侵襲の治療オプションを提供します。また、発展途上国における医療予算配分の増加が、市場成長に寄与することが期待されます。例えば、米国では、2020年の国民医療費は4.1兆米ドル、1人当たり12,530米ドルまで増加しました。 COVID-19のパンデミックは、世界中のさまざまな産業や取引に大混乱を引き起こしていました。高齢者は、さまざまな併存疾患や免疫抑制の可能性により、慢性的な痛みにさらされる可能性が高いため、神経調節の需要は高齢者層でより高くなっています。さらに、COVID-19ウイルスに感染した人々の間で需要が増加すると予想されます。この病気は、免疫系を効果的に抑制するのです。 医療インフラを改善するための政府や市場関係者による投資の大幅な増加は、神経症状を治療するための新規技術の導入を促進しています。2021年の連邦予算において、PM Atmanirbhar Swasth Bharat Yojanaは、インド政府から6年間で総額81億米ドルの資金を受け取りました。この資金は、既存の国立医療機関を強化し、一次、二次、三次医療システムの能力を開発し、新興疾患の検出に対応するために配分された。 この市場で事業を展開する主要企業は、自社製品についてFDAの認可を受けています。組織は、グローバルリーチを拡大しながら競争力を強化するために、提携、買収、パートナーシップ、研究開発投資、新製品の上市、承認などの戦略を取り入れています。例えば、2021年9月、アボットは、医療機器製造会社であるWalk Vascular, LLCを買収しました。Walk Vascular, LLCは、血栓の除去を目的とした低侵襲血栓除去システムで知られています。 神経調節デバイス市場レポートハイライト - 製品タイプ別では、脊髄刺激装置が2021年に40.0%超の収益シェアを獲得し、市場を支配しました。脳深部刺激装置は、本態性振戦、パーキンソン病、ジストニア、てんかんの治療への利用が増加していることから、予測期間中に10.8%の最速成長率を記録すると予想される - 技術別では、さまざまな神経疾患の治療に低侵襲治療の使用が増加していることから、2021年には内部セグメントが55.0%超のシェアを占めています。外部セグメントは、予測期間中に最も速いCAGR 10.8%で拡大すると予想されます。 - 用途別では、パーキンソン病分野が2021年に25.0%超の最大の収益シェアを占めた。慢性疼痛セグメントは予測期間中に11.3%の最速成長を示すと予想される - バイオマテリアルに基づくと、金属バイオマテリアルセグメントが市場を支配し、研究開発活動の成長により2021年に45.0%超のシェアを占めた - 2021年には、さまざまな種類の神経疾患の有病率が上昇し、神経調節デバイスや治療法のニーズが繰り返されていることから、北米が45.0%超の収益シェアで市場を支配した。アジア太平洋地域は、予測期間中に10.6%という最速の速度で拡大すると予想されています。この成長の背景には、人口の高齢化と政府の取り組みの増加があります。例えば、NITI Aayogは保健家族福祉省とともに、2016年に神経障害に苦しむ患者のための無償診断プログラムを開始した 目次Table of ContentsChapter 1 Report Scope and Objectives 1.1 Market Segmentation & Scope 1.2 Regional Scope 1.2.1 Estimates And Forecast Timeline 1.3 Objectives 1.3.1 Objective - 1 1.3.2 Objective - 2 1.3.3 Objective - 3 Chapter 2 Methodology 2.1 Research Methodology 2.2 Information Procurement 2.2.1 Purchased Database 2.2.2 GVR’s Internal Database 2.2.3 Secondary Sources 2.2.4 Primary Research 2.3 Information or Data Analysis 2.3.1 Data Analysis Models 2.4 Market Formulation & Validation 2.5 Model Details 2.5.1 Commodity Flow Analysis (Model 1) 2.5.2 Volume Price Analysis (Model 2) 2.6 List of Secondary Sources Chapter 3 Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.2.1 Product Type 3.2.2 Technology 3.2.3 Application 3.2.4 Biomaterial 3.2.5 End Use 3.2.6 Region 3.3 Competitive Insights 3.4 Neuromodulation Devices Market Outlook, 2021 Chapter 4 Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.1.1 Parent Market Outlook 4.1.2 Ancillary Market Outlook 4.2 Neuromodulation Devices Market Dynamics 4.2.1 Market Driver Analysis 4.2.1.1 Harnessing digital health solutions 4.2.1.2 A rise in the number of patients with neurological disorders 4.2.2 Market Restraint Analysis 4.2.2.1 Less number of skilled labor 4.3 Neuromodulation Devices Market: Business Environment Analysis Tools 4.3.1 Porter’s Five Forces Analysis 4.3.1.1 Threat of new entrants 4.3.1.2 Bargaining power of suppliers 4.3.1.3 Bargaining power of buyers 4.3.1.4 Competitive rivalry 4.3.1.5 Threat of substitutes 4.3.2 Pestel Analysis 4.3.2.1 Political & Legal 4.3.2.2 Economic & Social 4.3.2.3 Technological 4.3.2.4 Environmental 4.4 Penetration & Growth Prospect Mapping 4.5 Technology Trend Analysis 4.6 Regulatory Framework 4.7 Impact of COVID-19 on Neuromodulation Devices Market Chapter 5 Neuromodulation Devices Market: Product Type Analysis 5.1 Neuromodulation Devices Product Type Market Share Analysis, 2021 & 2030 5.2 Neuromodulation Devices Product Type Market: Segment Dashboard 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment 5.3.1 Spinal Cord Stimulators 5.3.1.1 Spinal cord stimulators market, 2017 - 2030 (USD Million) 5.3.2 Deep Brain Stimulators 5.3.2.1 Deep brain stimulators market, 2017 - 2030 (USD Million) 5.3.3 Sacral Nerve Stimulators 5.3.3.1 Sacral nerve stimulators market, 2017 - 2030 (USD Million) 5.3.4 Vagus Nerve Stimulators 5.3.4.1 Vagus nerve stimulators market, 2017 - 2030 (USD Million) 5.3.5 Transcranial Magnetic Stimulators 5.3.5.1 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million) 5.3.6 Others 5.3.6.1 Others market, 2017 - 2030 (USD Million) Chapter 6 Neuromodulation Devices Market: Technology Analysis 6.1 Neuromodulation Devices Technology Market Share Analysis, 2021 & 2030 6.2 Neuromodulation Devices technology Market: Segment Dashboard: 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Technology Segment 6.3.1 Internal 6.3.1.1 Internal market, 2017 - 2030 (USD Million) 6.3.2 External 6.3.2.1 External market, 2017 - 2030 (USD Million) Chapter 7 Neuromodulation Devices Market: Application Analysis 7.1 Neuromodulation Devices Application Market Share Analysis, 2021 & 2030 7.2 Neuromodulation Devices Application Market: Segment Dashboard 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment 7.3.1 Parkinson’s Disease 7.3.1.1 Parkinson’s disease market, 2017- 2030 (USD Million) 7.3.2 Chronic Pain 7.3.2.1 Chronic pain market, 2017 - 2030 (USD Million) 7.3.3 Migraine 7.3.3.1 Migraine market, 2017- 2030 (USD Million) 7.3.4 Epilepsy 7.3.4.1 Epilepsy market, 2017- 2030 (USD Million) 7.3.5 Tremor 7.3.5.1 Tremor market, 2017- 2030 (USD Million) 7.3.6 Depression 7.3.6.1 Depression market, 2017- 2030 (USD Million) 7.3.7 Urinary & Fecal Incontinence 7.3.7.1 Urinary & fecal incontinence, 2017- 2030 (USD Million) 7.3.8 Others 7.3.8.1 Others market, 2017- 2030 (USD Million) Chapter 8 Neuromodulation Devices Market: Biomaterial Analysis 8.1 Neuromodulation Devices Biomaterial Market Share Analysis, 2021 & 2030 8.2 Neuromodulation Devices Biomaterial Market: Segment Dashboard 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Biomaterial 8.3.1 Polymeric Biomaterial 8.3.1.1 Polymeric biomaterial market, 2017- 2030 (USD Million) 8.3.2 Metallic Biomaterial 8.3.2.1 Metallic biomaterial market, 2017 - 2030 (USD Million) 8.3.3 Ceramic Biomaterial 8.3.3.1 Ceramic biomaterial market, 2017- 2030 (USD Million) Chapter 9 Neuromodulation Devices Market: End-Use Analysis 9.1 Neuromodulation Devices Type Market Share Analysis, 2021 & 2030 9.2 Neuromodulation Devices Type Market: Segment Dashboard 9.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment 9.3.1 Clinics & Physiotherapy Centers 9.3.1.1 Clinics & physiotherapy centers market, 2017- 2030 (USD Million) 9.3.2 Hospitals & Ambulatory Centers 9.3.2.1 Hospitals & ambulatory centers market, 2017- 2030 (USD Million) 9.3.3 Others 9.3.3.1 Others market, 2017- 2030 (USD Million) Chapter 10 Neuromodulation Devices Market: Regional Analysis 10.1 Neuromodulation Devices Regional Market Share Analysis, 2021 & 2030 10.2 Regional Market Snapshot 10.3 North America 10.3.1 North America Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.3.2 U.S. 10.3.2.1 U.S. neuromodulation devices market, 2017 - 2030 (USD Million) 10.3.3 Canada 10.3.3.1 Canada neuromodulation devices market, 2017 - 2030 (USD Million) 10.4 Europe 10.4.1 Europe Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.4.2 U.K. 10.4.2.1 U.K. neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.3 Germany 10.4.3.1 Germany neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.4 France 10.4.4.1 France neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.5 Italy 10.4.5.1 Italy neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.6 Spain 10.4.6.1 Spain neuromodulation devices market, 2017 - 2030 (USD Million) 10.5 Asia Pacific 10.5.1 Asia Pacific Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.5.2 Japan 10.5.2.1 Japan neuromodulation devices market, 2017 - 2030 (USD Million) 10.5.3 China 10.5.3.1 China neuromodulation devices market, 2017 - 2030 (USD Million) 10.5.4 India 10.5.4.1 India neuromodulation devices market, 2017 - 2030 (USD Million) 10.6 Latin America 10.6.1 Latin America Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.6.2 Brazil 10.6.2.1 Brazil neuromodulation devices market, 2017 - 2030 (USD Million) 10.6.3 Mexico 10.6.3.1 Mexico neuromodulation devices market, 2017 - 2030 (USD Million) 10.7 Middle East and Africa (MEA) 10.7.1 MEA Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.7.2 South Africa 10.7.2.1 South Africa neuromodulation devices market, 2017 - 2030 (USD Million) Chapter 11 Competitive Analysis 11.1 Recent Developments & Impact Analysis, By Key Market Participants 11.2 Company Profiles 11.2.1 MEDTRONIC 11.2.1.1 Company overview 11.2.1.2 Financial performance 11.2.1.3 Product benchmarking 11.2.1.4 Strategic initiatives 11.2.2 LIVANOVA PLC 11.2.2.1 Company overview 11.2.2.2 Financial performance 11.2.2.3 Product benchmarking 11.2.2.4 Strategic initiatives 11.2.3 NEVRO CORPORATION 11.2.3.1 Company overview 11.2.3.2 Financial performance 11.2.3.3 Product benchmarking 11.2.3.4 Strategic initiatives 11.2.4 BIOVENTUS INC. 11.2.4.1 Company overview 11.2.4.2 Financial performance 11.2.4.3 Product benchmarking 11.2.4.4 Strategic initiatives 11.2.5 NEUROPACE INC. 11.2.5.1 Company overview 11.2.5.2 Financial performance 11.2.5.3 Product benchmarking 11.2.5.4 Strategic initiatives 11.2.6 BOSTON SCIENTIFIC CORPORATION 11.2.6.1 Company overview 11.2.6.2 Financial performance 11.2.6.3 Product benchmarking 11.2.6.4 Strategic initiatives 11.2.7 ABBOTT LABORATORIES 11.2.7.1 Company overview 11.2.7.2 Financial performance 11.2.7.3 Product benchmarking 11.2.7.4 Strategic initiative 11.2.8 NEURONETICS 11.2.8.1 Company overview 11.2.8.2 Financial performance 11.2.8.3 Product benchmarking 11.2.8.4 Strategic initiatives 11.2.9 INSPIRE MEDICAL SYSTEM INC. 11.2.9.1 Company overview 11.2.9.2 Fperformance 11.2.9.3 Product benchmarking 11.2.9.4 Strategic initiatives 11.2.10 ELECTROCORE INC. 11.2.10.1 Company overview 11.2.10.2 Financial performance 11.2.10.3 Product benchmarking 11.2.10.4 Strategic initiatives
SummaryNeuromodulation Devices Market Growth & Trends Table of ContentsTable of ContentsChapter 1 Report Scope and Objectives 1.1 Market Segmentation & Scope 1.2 Regional Scope 1.2.1 Estimates And Forecast Timeline 1.3 Objectives 1.3.1 Objective - 1 1.3.2 Objective - 2 1.3.3 Objective - 3 Chapter 2 Methodology 2.1 Research Methodology 2.2 Information Procurement 2.2.1 Purchased Database 2.2.2 GVR’s Internal Database 2.2.3 Secondary Sources 2.2.4 Primary Research 2.3 Information or Data Analysis 2.3.1 Data Analysis Models 2.4 Market Formulation & Validation 2.5 Model Details 2.5.1 Commodity Flow Analysis (Model 1) 2.5.2 Volume Price Analysis (Model 2) 2.6 List of Secondary Sources Chapter 3 Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.2.1 Product Type 3.2.2 Technology 3.2.3 Application 3.2.4 Biomaterial 3.2.5 End Use 3.2.6 Region 3.3 Competitive Insights 3.4 Neuromodulation Devices Market Outlook, 2021 Chapter 4 Market Variables, Trends & Scope 4.1 Market Lineage Outlook 4.1.1 Parent Market Outlook 4.1.2 Ancillary Market Outlook 4.2 Neuromodulation Devices Market Dynamics 4.2.1 Market Driver Analysis 4.2.1.1 Harnessing digital health solutions 4.2.1.2 A rise in the number of patients with neurological disorders 4.2.2 Market Restraint Analysis 4.2.2.1 Less number of skilled labor 4.3 Neuromodulation Devices Market: Business Environment Analysis Tools 4.3.1 Porter’s Five Forces Analysis 4.3.1.1 Threat of new entrants 4.3.1.2 Bargaining power of suppliers 4.3.1.3 Bargaining power of buyers 4.3.1.4 Competitive rivalry 4.3.1.5 Threat of substitutes 4.3.2 Pestel Analysis 4.3.2.1 Political & Legal 4.3.2.2 Economic & Social 4.3.2.3 Technological 4.3.2.4 Environmental 4.4 Penetration & Growth Prospect Mapping 4.5 Technology Trend Analysis 4.6 Regulatory Framework 4.7 Impact of COVID-19 on Neuromodulation Devices Market Chapter 5 Neuromodulation Devices Market: Product Type Analysis 5.1 Neuromodulation Devices Product Type Market Share Analysis, 2021 & 2030 5.2 Neuromodulation Devices Product Type Market: Segment Dashboard 5.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Type Segment 5.3.1 Spinal Cord Stimulators 5.3.1.1 Spinal cord stimulators market, 2017 - 2030 (USD Million) 5.3.2 Deep Brain Stimulators 5.3.2.1 Deep brain stimulators market, 2017 - 2030 (USD Million) 5.3.3 Sacral Nerve Stimulators 5.3.3.1 Sacral nerve stimulators market, 2017 - 2030 (USD Million) 5.3.4 Vagus Nerve Stimulators 5.3.4.1 Vagus nerve stimulators market, 2017 - 2030 (USD Million) 5.3.5 Transcranial Magnetic Stimulators 5.3.5.1 Transcranial magnetic stimulators market, 2017 - 2030 (USD Million) 5.3.6 Others 5.3.6.1 Others market, 2017 - 2030 (USD Million) Chapter 6 Neuromodulation Devices Market: Technology Analysis 6.1 Neuromodulation Devices Technology Market Share Analysis, 2021 & 2030 6.2 Neuromodulation Devices technology Market: Segment Dashboard: 6.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Technology Segment 6.3.1 Internal 6.3.1.1 Internal market, 2017 - 2030 (USD Million) 6.3.2 External 6.3.2.1 External market, 2017 - 2030 (USD Million) Chapter 7 Neuromodulation Devices Market: Application Analysis 7.1 Neuromodulation Devices Application Market Share Analysis, 2021 & 2030 7.2 Neuromodulation Devices Application Market: Segment Dashboard 7.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Application Segment 7.3.1 Parkinson’s Disease 7.3.1.1 Parkinson’s disease market, 2017- 2030 (USD Million) 7.3.2 Chronic Pain 7.3.2.1 Chronic pain market, 2017 - 2030 (USD Million) 7.3.3 Migraine 7.3.3.1 Migraine market, 2017- 2030 (USD Million) 7.3.4 Epilepsy 7.3.4.1 Epilepsy market, 2017- 2030 (USD Million) 7.3.5 Tremor 7.3.5.1 Tremor market, 2017- 2030 (USD Million) 7.3.6 Depression 7.3.6.1 Depression market, 2017- 2030 (USD Million) 7.3.7 Urinary & Fecal Incontinence 7.3.7.1 Urinary & fecal incontinence, 2017- 2030 (USD Million) 7.3.8 Others 7.3.8.1 Others market, 2017- 2030 (USD Million) Chapter 8 Neuromodulation Devices Market: Biomaterial Analysis 8.1 Neuromodulation Devices Biomaterial Market Share Analysis, 2021 & 2030 8.2 Neuromodulation Devices Biomaterial Market: Segment Dashboard 8.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the Biomaterial 8.3.1 Polymeric Biomaterial 8.3.1.1 Polymeric biomaterial market, 2017- 2030 (USD Million) 8.3.2 Metallic Biomaterial 8.3.2.1 Metallic biomaterial market, 2017 - 2030 (USD Million) 8.3.3 Ceramic Biomaterial 8.3.3.1 Ceramic biomaterial market, 2017- 2030 (USD Million) Chapter 9 Neuromodulation Devices Market: End-Use Analysis 9.1 Neuromodulation Devices Type Market Share Analysis, 2021 & 2030 9.2 Neuromodulation Devices Type Market: Segment Dashboard 9.3 Market Size & Forecasts and Trend Analyses, 2017 to 2030 for the End-Use Segment 9.3.1 Clinics & Physiotherapy Centers 9.3.1.1 Clinics & physiotherapy centers market, 2017- 2030 (USD Million) 9.3.2 Hospitals & Ambulatory Centers 9.3.2.1 Hospitals & ambulatory centers market, 2017- 2030 (USD Million) 9.3.3 Others 9.3.3.1 Others market, 2017- 2030 (USD Million) Chapter 10 Neuromodulation Devices Market: Regional Analysis 10.1 Neuromodulation Devices Regional Market Share Analysis, 2021 & 2030 10.2 Regional Market Snapshot 10.3 North America 10.3.1 North America Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.3.2 U.S. 10.3.2.1 U.S. neuromodulation devices market, 2017 - 2030 (USD Million) 10.3.3 Canada 10.3.3.1 Canada neuromodulation devices market, 2017 - 2030 (USD Million) 10.4 Europe 10.4.1 Europe Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.4.2 U.K. 10.4.2.1 U.K. neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.3 Germany 10.4.3.1 Germany neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.4 France 10.4.4.1 France neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.5 Italy 10.4.5.1 Italy neuromodulation devices market, 2017 - 2030 (USD Million) 10.4.6 Spain 10.4.6.1 Spain neuromodulation devices market, 2017 - 2030 (USD Million) 10.5 Asia Pacific 10.5.1 Asia Pacific Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.5.2 Japan 10.5.2.1 Japan neuromodulation devices market, 2017 - 2030 (USD Million) 10.5.3 China 10.5.3.1 China neuromodulation devices market, 2017 - 2030 (USD Million) 10.5.4 India 10.5.4.1 India neuromodulation devices market, 2017 - 2030 (USD Million) 10.6 Latin America 10.6.1 Latin America Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.6.2 Brazil 10.6.2.1 Brazil neuromodulation devices market, 2017 - 2030 (USD Million) 10.6.3 Mexico 10.6.3.1 Mexico neuromodulation devices market, 2017 - 2030 (USD Million) 10.7 Middle East and Africa (MEA) 10.7.1 MEA Neuromodulation Devices Market, 2017 - 2030 (USD Million) 10.7.2 South Africa 10.7.2.1 South Africa neuromodulation devices market, 2017 - 2030 (USD Million) Chapter 11 Competitive Analysis 11.1 Recent Developments & Impact Analysis, By Key Market Participants 11.2 Company Profiles 11.2.1 MEDTRONIC 11.2.1.1 Company overview 11.2.1.2 Financial performance 11.2.1.3 Product benchmarking 11.2.1.4 Strategic initiatives 11.2.2 LIVANOVA PLC 11.2.2.1 Company overview 11.2.2.2 Financial performance 11.2.2.3 Product benchmarking 11.2.2.4 Strategic initiatives 11.2.3 NEVRO CORPORATION 11.2.3.1 Company overview 11.2.3.2 Financial performance 11.2.3.3 Product benchmarking 11.2.3.4 Strategic initiatives 11.2.4 BIOVENTUS INC. 11.2.4.1 Company overview 11.2.4.2 Financial performance 11.2.4.3 Product benchmarking 11.2.4.4 Strategic initiatives 11.2.5 NEUROPACE INC. 11.2.5.1 Company overview 11.2.5.2 Financial performance 11.2.5.3 Product benchmarking 11.2.5.4 Strategic initiatives 11.2.6 BOSTON SCIENTIFIC CORPORATION 11.2.6.1 Company overview 11.2.6.2 Financial performance 11.2.6.3 Product benchmarking 11.2.6.4 Strategic initiatives 11.2.7 ABBOTT LABORATORIES 11.2.7.1 Company overview 11.2.7.2 Financial performance 11.2.7.3 Product benchmarking 11.2.7.4 Strategic initiative 11.2.8 NEURONETICS 11.2.8.1 Company overview 11.2.8.2 Financial performance 11.2.8.3 Product benchmarking 11.2.8.4 Strategic initiatives 11.2.9 INSPIRE MEDICAL SYSTEM INC. 11.2.9.1 Company overview 11.2.9.2 Fperformance 11.2.9.3 Product benchmarking 11.2.9.4 Strategic initiatives 11.2.10 ELECTROCORE INC. 11.2.10.1 Company overview 11.2.10.2 Financial performance 11.2.10.3 Product benchmarking 11.2.10.4 Strategic initiatives
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(高分子材料)の最新刊レポート
Grand View Research社の高分子材料分野での最新刊レポート
本レポートと同じKEY WORD(biomaterial)の最新刊レポート
よくあるご質問Grand View Research社はどのような調査会社ですか?グランドビューリサーチ(Grand View Research)は通信技術、化学品、材料、ヘルスケア、エネルギーなど広範な市場を対象にした調査報告書を出版しています。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/14 10:27 156.77 円 166.04 円 201.95 円 |